MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: When seen against previous studies,47, 48, 49 the novelty of this study lies in that high Evi1 could distinguish CML-CP stem cells even from SLAM-LSK cells or non-SLAM-LSK cells.